The Latin America, Middle East and Africa Parenteral Nutrition Market would witness market growth of 9% CAGR during the forecast period (2021-2027).
Malnutrition is one of the major driving factors for the development of the parenteral nutrition market. As per the UNICEF, if an infant suffers malnutrition during his first 1,000 days of life could result in impaired cognitive ability and unstable growth. The diet of an infant should have an appropriate balance of vitamins, starch, amino acids, minerals, and lipids. These necessary nutrients can be administered through parenteral nutrition, which is likely to accelerate the growth of the parenteral nutrition market during the forecasting period.
The surge in the occurrences of chronic diseases like cancer positively impacts the adoption of parenteral nutrition across the globe. In addition, parenteral nutrition is extremely beneficial in the administration of essential nutrition that is highly helpful for strength, hydration, and energy level among the patients during their treatment.
The region is witnessing a constant surge in the number of premature infants who are highly vulnerable to stunt growth and catching infections. Therefore, early parenteral nutrition is crucial for preterm infants and must transfer appropriate amino acids & energy. The market players are capitalizing on this opportunity by actively entering the regional market and putting investments in different strategies in order to gain a competitive edge.
High accessibility with ultra-modern supply chain solutions is expected to fuel the growth of the regional parenteral nutrition market in the upcoming years. Moreover, the adoption of parenteral nutrition has been increased in end-user verticals such as diagnostic centers, hospitals, and clinics in order to avoid infections and to maintain hygiene levels. Hence, these factors would open new avenues for growth for the regional parenteral nutrition market.
The Single Dose Amino Acid Solution market dominated the South Africa Parenteral Nutrition Market by Nutrient Type in 2020, thereby, achieving a market value of $54.6 million by 2027. The Parenteral Lipid Emulsion market is estimated to grow at a CAGR of 8.8% during (2021 - 2027). Additionally, The Carbohydrates market is expected to witness highest CAGR of 10.3% during (2021 - 2027).
Based on Nutrient Type, the market is segmented into Single Dose Amino Acid Solution, Parenteral Lipid Emulsion, Carbohydrates, Trace Elements, and Vitamins & Minerals. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
Free Valuable Insights: The Global Parenteral Nutrition Market is Predict to reach $10.9 Billion by 2027, at a CAGR of 8.1%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vifor Pharma Management Ltd., Baxter International, Inc., Allergan PLC (AbbVie), B. Braun Melsungen AG, Fresenius SE & Co. KGaA, Grifols S.A., Pfizer, Inc., ICU Medical, Inc., Anhui Medipharm Co., Ltd. and Aculife Healthcare Private Limited.
Scope of the Study
Market Segments Covered in the Report:
By Nutrient Type
- Single Dose Amino Acid Solution
- Parenteral Lipid Emulsion
- Carbohydrates
- Trace Elements,
- Vitamins & Minerals
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Vifor Pharma Management Ltd.
- Baxter International, Inc.
- Allergan PLC (AbbVie)
- B.Braun Melsungen AG
- Fresenius SE & Co. KGaA
- Grifols S.A.
- Pfizer, Inc.
- ICU Medical, Inc.
- Anhui Medipharm Co., Ltd.
- Aculife Healthcare Private Limited
Chapter 1. Market Scope & Methodology
1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Parenteral Nutrition Market, by Nutrient Type
1.4.2 LAMEA Parenteral Nutrition Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 COVID-19 Impact
2.1.1.2 Market Composition and Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Parenteral Nutrition Market by Nutrient Type
3.1 LAMEA Single Dose Amino Acid Solution Market by Country
3.2 LAMEA Parenteral Lipid Emulsion Market by Country
3.3 LAMEA Carbohydrates Market by Country
3.4 LAMEA Trace Elements Market by Country
3.5 LAMEA Other Nutrient Type Market by Country
Chapter 4. LAMEA Parenteral Nutrition Market by Country
4.1 Brazil Parenteral Nutrition Market
4.1.1 Brazil Parenteral Nutrition Market by Nutrient Type
4.2 Argentina Parenteral Nutrition Market
4.2.1 Argentina Parenteral Nutrition Market by Nutrient Type
4.3 UAE Parenteral Nutrition Market
4.3.1 UAE Parenteral Nutrition Market by Nutrient Type
4.4 Saudi Arabia Parenteral Nutrition Market
4.4.1 Saudi Arabia Parenteral Nutrition Market by Nutrient Type
4.5 South Africa Parenteral Nutrition Market
4.5.1 South Africa Parenteral Nutrition Market by Nutrient Type
4.6 Nigeria Parenteral Nutrition Market
4.6.1 Nigeria Parenteral Nutrition Market by Nutrient Type
4.7 Rest of LAMEA Parenteral Nutrition Market
4.7.1 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type
Chapter 5. Company Profiles
5.1 Vifor Pharma Management Ltd.
5.1.1 Company Overview
5.1.2 Financial Analysis
5.1.3 Research & Development Expenses
5.2 Baxter International, Inc.
5.2.1 Company Overview
5.2.2 Financial Analysis
5.2.3 Regional Analysis
5.2.4 Research & Development Expense
5.2.1 Recent strategies and developments:
5.2.1.1 Partnerships, Collaborations, and Agreements:
5.2.1.2 Product Launches and Product Expansions:
5.2.1.3 Approvals and Trails:
5.3 Allergan PLC (AbbVie)
5.3.1 Company Overview
5.3.2 Financial Analysis
5.3.3 Regional Analysis
5.3.4 Research & Development Expense
5.4 B. Braun Melsungen AG
5.4.1 Company Overview
5.4.2 Financial Analysis
5.4.3 Segmental and Regional Analysis
5.4.4 Research & Development Expenses
5.5 Fresenius SE & Co. KGaA
5.5.1 Company Overview
5.5.2 Financial Analysis
5.5.3 Segmental and Regional Analysis
5.5.4 Research & Development Expenses
5.6 Grifols S.A.
5.6.1 Company Overview
5.6.2 Financial Analysis
5.6.3 Segmental and Regional Analysis
5.6.4 Research & Development Expense
5.7 Pfizer, Inc.
5.7.1 Company Overview
5.7.2 Financial Analysis
5.7.3 Regional Analysis
5.7.4 Research & Development Expenses
5.8 ICU Medical, Inc.
5.8.1 Company Overview
5.8.2 Recent strategies and developments:
5.8.2.1 Partnerships, Collaborations, and Agreements:
5.9 Anhui Medipharm Co., Ltd.
5.9.1 Company Overview
5.10. Aculife Healthcare Private Limited
5.10.1 Company Overview
TABLE 1 LAMEA Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 2 LAMEA Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 3 LAMEA Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 4 LAMEA Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 5 LAMEA Single Dose Amino Acid Solution Market by Country, 2017 - 2020, USD Million
TABLE 6 LAMEA Single Dose Amino Acid Solution Market by Country, 2021 - 2027, USD Million
TABLE 7 LAMEA Parenteral Lipid Emulsion Market by Country, 2017 - 2020, USD Million
TABLE 8 LAMEA Parenteral Lipid Emulsion Market by Country, 2021 - 2027, USD Million
TABLE 9 LAMEA Carbohydrates Market by Country, 2017 - 2020, USD Million
TABLE 10 LAMEA Carbohydrates Market by Country, 2021 - 2027, USD Million
TABLE 11 LAMEA Trace Elements Market by Country, 2017 - 2020, USD Million
TABLE 12 LAMEA Trace Elements Market by Country, 2021 - 2027, USD Million
TABLE 13 LAMEA Other Nutrient Type Market by Country, 2017 - 2020, USD Million
TABLE 14 LAMEA Other Nutrient Type Market by Country, 2021 - 2027, USD Million
TABLE 15 LAMEA Parenteral Nutrition Market by Country, 2017 - 2020, USD Million
TABLE 16 LAMEA Parenteral Nutrition Market by Country, 2021 - 2027, USD Million
TABLE 17 Brazil Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 18 Brazil Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 19 Brazil Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 20 Brazil Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 21 Argentina Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 22 Argentina Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 23 Argentina Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 24 Argentina Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 25 UAE Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 26 UAE Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 27 UAE Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 28 UAE Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 29 Saudi Arabia Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 30 Saudi Arabia Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 31 Saudi Arabia Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 32 Saudi Arabia Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 33 South Africa Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 34 South Africa Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 35 South Africa Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 36 South Africa Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 37 Nigeria Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 38 Nigeria Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 39 Nigeria Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 40 Nigeria Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 41 Rest of LAMEA Parenteral Nutrition Market, 2017 - 2020, USD Million
TABLE 42 Rest of LAMEA Parenteral Nutrition Market, 2021 - 2027, USD Million
TABLE 43 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type, 2017 - 2020, USD Million
TABLE 44 Rest of LAMEA Parenteral Nutrition Market by Nutrient Type, 2021 - 2027, USD Million
TABLE 45 Key Information – Vifor Pharma Management Ltd.
TABLE 46 Key Information – Baxter International, Inc.
TABLE 47 Key Information – Allergan PLC
TABLE 48 key Information – B. Braun Melsungen AG
TABLE 49 key information – Fresenius SE & Co. KGaA
TABLE 50 key information – Grifols S.A.
TABLE 51 Key Information – Pfizer, Inc.
TABLE 52 key information – ICU Medical, Inc.
TABLE 53 Key Information – Anhui Medipharm Co., Ltd.
TABLE 54 Key Information – ACULIFE HEALTHCARE PRIVATE LIMITED
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Baxter International, Inc.